Aragen Integrated Drug Discovery (AIDD) platform brings together the strength of our in-house drug discovery capabilities, data science and structural biology/crystallography with a strong focus on efficiency, accuracy and savings.
Target Identification & validation
Our commitment:
We have implemented a digital platform for ‘Design-Make-Test-Analyze’ (DMTA) cycle and compound data management system (CDMS) for effective project management.
Create, capture and track all designs, hypotheses and challenges
Analyze results at the end of the process and capture learning
Track progress and delivery of agreed synthesis targets
Schedule and manage test requests Clear communication of test status
CDMS is designed to have an integrated digital process platform from compound registration to assay results and data storage for analysis. IDD’s partners can directly monitor the projects in real time and make compound assay requests directly from partner’s location.
This platform is an integration of digital tools as well as customised automated platforms for data acquisition, data transfer and data analysis. It is the integrated discovery workflow for CADD-Medchem-Biology-DMPK that ensures easy tracking, smooth data transfer and clear visualization across the various project stake holders.
